Cannabis finance news

Zelira share price rockets as study shows cannabinoid drug outperforms multibillion dollar Pfizer product

by Steve Jones June 1, 2023April 30, 2024

ASX-listed Zelira Therapeutics saw its share price soar 230% yesterday after revealing its cannabinoid medication for […]

Creditors advised to wind up BBS Pharmaceuticals as investigations continue into firm’s financial affairs

by Steve Jones June 1, 2023April 30, 2024

Cannabiz Awards 2023 sold out

by cannabiz team May 31, 2023April 30, 2024

Wellnex Life snaps up topical pain relief brand to complement medicinal cannabis strategy

by Martin Lane May 29, 2023April 30, 2024

Last few days to secure your spot at the Cannabiz Awards

by cannabiz team May 24, 2023April 30, 2024

Zelira

Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma

by Martin Lane and Steve Jones May 23, 2023April 30, 2024

Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global

by Martin Lane and Steve Jones May 18, 2023April 30, 2024

Cannaponics strengthens board as crowdfunding campaign hits A$5m maximum

by Martin Lane May 17, 2023April 30, 2024

Creso hits back after ASX questions firm’s ability to remain listed

by Steve Jones May 16, 2023April 30, 2024